EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neuronal Enriched Extracellular Vesicle miR-122-5p as a Potential Biomarker for Alzheimer’s Disease

Kumudu Subasinghe iD, Courtney Hall, Megan Rowe iD, Zhengyang Zhou, Robert Barber iD, Nicole Phillips

Cells · 13.11.2025 · 14 (22) · 1784

DOI: 10.3390/cells14221784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 13.11.2025. Verfasst von Kumudu Subasinghe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Genetics, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, Extracellular Vesicles, Neurons. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Texas Alzheimer's Research and Care Consortium under the direction of the Texas Council on AD and Related Disorder, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the leading cause of dementia and is often prefaced by mild cognitive impairment (MCI). Detection of AD-related changes via blood-based biomarkers would enable critical therapeutic interventions early in disease progression. Neuronal enriched extracellular vesicle (NEEV) miRNAs regulate peripheral genes as a response to early AD brain changes and hence may have biomarker potential. Plasma NEEVs were captured from plasma samples of Mexican Americans (MAs) and Non-Hispanic Whites (NHWs) using an antibody against the neuronal surface marker CD171. miRNAs isolated from NEEVs were sequenced and analyzed using miRDeep2/DEseq2 and QIAGEN RNA-seq portal for differential expression between cognitively impaired (CI) and cognitively unimpaired controls. hsa-miR-122-5p was significantly underrepresented in the CI group in both MAs and NHWs compared to the healthy control. Other population-specific miRNAs (MAs: hsa-miR-26a-5p, hsa-let-7f-5p, and hsa-miR-139-5p, NHWs: hsa-miR-133a-3p, hsa-miR-125b-5p, and hsa-miR-100-5p) identified may have biomarker potential in AD precision medicine. Some of these differentially expressed miRNAs were associated with key AD-related comorbidities such as APOE genotype, age, and metabolic burden and were predicted to target genes within NF-κB -regulated inflammatory pathways. Together, these findings suggest that dysregulated miRNA networks may serve as a mechanistic link between comorbidity burden and AD-related neuroinflammation and neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicroRNAsExtracellular VesiclesNeuronsHumansBiomarkersMaleFemaleAgedCognitive DysfunctionAged, 80 and overCase-Control Studies

Stichwörter der Autor:innen

Alzheimer’s disease (AD)Cognitive Impairment (CI)Extracellular Vesicles (EVs)Mexican Americans (MAs)MicroRNA (miRNA)Neuronal Enriched Extracellular Vesicles (NEEVs)Non-Hispanic Whites (NHWs)

Substanzen

MicroRNAsBiomarkersMIRN122 microRNA, human

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Genetics, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
  • Department of Biomedical Engineering, Johns Hopkins University, 3400 N Charles St, Baltimore, MD 21201, USA.
  • Department of Population and Community Health, College of Public Health, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
  • Department of Family Medicine & Manipulative Medicine, Texas College of Osteopathic Medicine, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
  • Institute for Translational Medicine, UNT Health, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.

ORCID-Profile: Kumudu Subasinghe, Megan Rowe, Robert Barber

Förderung

  • NIA NIH HHS
  • Texas Alzheimer's Research and Care Consortium under the direction of the Texas Council on AD and Related Disorder
  • NIH HHS
  • Texas Alzheimer’s Research and Care Consortium
  • National Institutes of Health; Neurobiology of Aging and Alzheimer’s Disease Training Grant

Zitieren

APA

Subasinghe, K., Hall, C., Rowe, M., Zhou, Z., Barber, R., & Phillips, N. (2025). Neuronal Enriched Extracellular Vesicle miR-122-5p as a Potential Biomarker for Alzheimer’s Disease. Cells, 14(22), 1784. https://doi.org/10.3390/cells14221784

Vancouver

Subasinghe K, Hall C, Rowe M, Zhou Z, Barber R, Phillips N. Neuronal Enriched Extracellular Vesicle miR-122-5p as a Potential Biomarker for Alzheimer’s Disease. Cells. 2025;14(22):1784. doi:10.3390/cells14221784

BibTeX
@article{Subasinghe2025,
  author = {Subasinghe, Kumudu and Hall, Courtney and Rowe, Megan and Zhou, Zhengyang and Barber, Robert and Phillips, Nicole},
  title = {Neuronal Enriched Extracellular Vesicle miR-122-5p as a Potential Biomarker for Alzheimer’s Disease},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {22},
  pages = {1784},
  doi = {10.3390/cells14221784}
}
Kostenlos starten →